Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study

被引:0
|
作者
Mao, R. [1 ]
He, Y. [1 ]
Ben-Horin, S. [2 ]
Chen, M. -H. [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Sheba Med Ctr, Tel Aviv, Israel
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P441
引用
收藏
页码:S300 / S301
页数:2
相关论文
共 50 条
  • [1] Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
    He, Yao
    Mao, Ren
    Chen, Fang
    Xu, Ping-Ping
    Chen, Bai-Li
    Wu, Yun
    Qiu, Yun
    Zhang, Sheng-Hong
    Feng, Rui
    Zeng, Zhi-Rong
    Ben-Horin, Shomron
    Chen, Min-Hu
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (05) : 397 - 406
  • [2] Thalidomide Induces Mucosal Healing in Crohn's Disease
    Lazzerini, M.
    Maschio, M.
    Martelossi, S.
    Di Leo, D.
    Ventura, A.
    WCPGHAN 3: WORLD CONGRESS OF PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION, 2008, : 13 - +
  • [3] MUCOSAL HEALING AND CLINICAL REMISSION AFTER TREATMENT WITH ADALIMUMAB IN SMALL INTESTINAL CROHN'S DISEASE (SIMCHA STUDY): FINAL RESULTS FROM A PROSPECTIVE, OPEN-LABEL, SINGLEARM STUDY
    Wetwittayakhlang, Panu
    Golovics, Petra A.
    Hahn, Gustavo
    Bessissow, Talat
    Bitton, Alain
    Afif, Waqqas
    Wild, Gary
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2022, 162 (07) : S823 - S823
  • [4] Thalidomide induces mucosal healing in Crohn's disease: Case report
    Márcio Rios Leite
    Sandra Sousa Santos
    André Castro Lyra
    Jaciane Mota
    Genoile Oliveira Santana
    World Journal of Gastroenterology, 2011, 17 (45) : 5028 - 5031
  • [5] Thalidomide induces mucosal healing in Crohn's disease: Case report
    Leite, Marcio Rios
    Santos, Sandra Sousa
    Lyra, Andre Castro
    Mota, Jaciane
    Santana, Genoile Oliveira
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (45) : 5028 - 5031
  • [6] Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
    Wetwittayakhlang, P.
    Golovics, P.
    Hahn, G.
    Bessissow, T.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I343 - I344
  • [7] Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
    Wetwittayakhlang, P.
    Golovics, P.
    Hahn, G.
    Bessissow, T.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I343 - I344
  • [8] An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
    Sabate, JM
    Villarejo, J
    Lemann, M
    Bonnet, J
    Allez, M
    Modigliani, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1117 - 1124
  • [9] An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
    Sabate, JM
    Villarejo, J
    Lemann, M
    Bonnet, J
    Allez, M
    Modigliani, R
    GASTROENTEROLOGY, 2002, 122 (04) : A498 - A498
  • [10] Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study
    Wetwittayakhlang, Panu
    Verdon, Christine
    Starr, Michael
    Hahn, Gustavo Drugg
    Golovics, Petra A.
    Bessissow, Talat
    Afif, Waqqas
    Wild, Gary
    Bitton, Alain
    Lakatos, Peter L.
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (06): : 603 - 610